Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Weill Cornell Medicine AR compound #15
- Development stage
- Unknown
- Lead developer
- Weill Cornell Medicine
- Modality
- Small Molecules
01
Overview
Weill Cornell Medicine AR compound #15: sourced facts only. name: "Medicinal chemistry-driven structure-activity relationship studies yielded compound #15, a potent and selective small molecule that rapidly induces AR-fl and AR-V7 degradation." [DOI:10.1158/1538-7445.am2026-lb346]; target: "Medicinal chemistry-driven structure-activity relationship studies yielded compound #15, a potent and selective small molecule that rapidly induces AR-fl and AR-V7 degradation." [DOI:10.1158/1538-7445.am2026-lb346]; developer: "Weill Cornell Medicine, New York, NY." [DOI:10.1158/1538-7445.am2026-lb346]; modality: "Medicinal chemistry-driven structure-activity relationship studies yielded compound #15, a potent and selective small molecule that rapidly induces AR-fl and AR-V7 degradation." [DOI:10.1158/1538-7445.am2026-lb346]
Beyond the preview
Go deeper on Weill Cornell Medicine AR compound #15.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Weill Cornell Medicine AR compound #15.